Nevertheless, expression has been observed in other types of tumours; CD34 expression can be detected in other fibroblastic and myofibroblastic tumours but is lost in aggressive SFTs, whereas BCL-2 is expressed in other fibroblastic spindle cell sarcomas. This evidence concerns the gene BCL2 and spindle cell sarcoma.